Evidence Hub

Genomic characterization of a mobile-element-associated resistance island in trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia isolates sharing the same PFGE genotype

Altan G, Rakıcı E, Dündar D, Özgümüş OB

Frontiers in cellular and infection microbiology, 2026

Abstract

Background: Stenotrophomonas maltophilia is an opportunistic nosocomial pathogen with intrinsic multidrug resistance and limited therapeutic options. This study integrated phenotypic susceptibility testing, targeted molecular screening, PFGE and short-read whole-genome sequencing (WGS) to characterize resistance determinants and their local genomic context in clinical-culture isolates.

Methods: Thirty-four non-duplicate clinical-culture isolates were analyzed. Susceptibility to trimethoprim-sulfamethoxazole (TMP-SMX), levofloxacin and minocycline was determined by disk diffusion. Minocycline testing was repeated with acceptable quality control, and the repeat-run zone records were reassessed using current CLSI breakpoints. A predefined, hypothesis-driven PCR panel was used to screen selected resistance-, efflux- and biofilm-associated targets, and gyrA, gyrB, parC and parE were sequenced. Genetic relatedness was assessed by XbaI-PFGE. Three selected isolates (S05, S08 and S25) underwent WGS as a targeted genomic-context analysis rather than a whole-collection population-genomic study.

Results: Resistance rates were 5.9% for TMP-SMX, 8.8% for levofloxacin and 11.8% for minocycline after reassessment using current CLSI minocycline breakpoints. Smqnr- and sul1-target PCR positivity was observed in 61.8% and 8.8% of isolates, respectively. A dfrA27-target PCR amplicon was observed in 82.4% of isolates but was not associated with TMP-SMX resistance and was not confirmed in the…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free